Vollenweider F, Benjannet S, Decroly E, Savaria D, Lazure C, Thomas G, Chrétien M, Seidah N G
J.A. DeSève Laboratories of Biochemical and Molecular Neuroendocrinology, Montréal, Québec, Canada.
Biochem J. 1996 Mar 1;314 ( Pt 2)(Pt 2):521-32. doi: 10.1042/bj3140521.
We present here the pulse and pulse-chase analysis of the biosynthesis of the envelope glycoprotein gp160 and its intracellular processing by the subtilisin/kexin-like convertases furin, PACE4, PC1, PC5 and its isoform PC5/6-B. We demonstrate that furin and to a much lesser extent PACE4, PC5/6-B and PC1 are candidate enzymes capable of processing gp160 intracellularly. Furthermore we show that furin can also process gp160/gp120 into gp77/gp53 products by cleavage at the sequence RIQR/GPGR just preceding the conserved GPGR structure found at the tip of the hypervariable V3 loop. The results show that processing into gp120 could occur at or before the trans-Golgi network (TGN) where sulphation of the oligosaccharide moieties of gp160 was detected. In contrast, the formation of gp77/gp53 by furin is a late event occurring after exit from the TGN. Our data also revealed that the alpha glucosidase I inhibitor N-butyldeoxynojirimycin, although affecting the oligosaccharide composition of gp160, does not impair the processing of either gp160 or gp120 by either furin or PACE4. Finally, the co-expression of the [Arg355, Arg358]-alpha-1-antitrypsin Portland variant was shown to potently inhibit the processing of both gp160 and gp120 by these convertases.
我们在此展示包膜糖蛋白gp160生物合成及其由枯草杆菌蛋白酶/凯新样转化酶弗林蛋白酶、PACE4、PC1、PC5及其同工型PC5/6 - B进行细胞内加工的脉冲和脉冲追踪分析。我们证明弗林蛋白酶以及程度小得多的PACE4、PC5/6 - B和PC1是能够在细胞内加工gp160的候选酶。此外,我们表明弗林蛋白酶还能通过在高变V3环顶端保守的GPGR结构之前的RIQR/GPGR序列处切割,将gp160/gp120加工成gp77/gp53产物。结果表明,加工成gp120可能发生在反式高尔基体网络(TGN)处或之前,在TGN处检测到了gp160寡糖部分的硫酸化。相比之下,弗林蛋白酶形成gp77/gp53是在从TGN出来后发生的晚期事件。我们的数据还显示,α - 葡萄糖苷酶I抑制剂N - 丁基脱氧野尻霉素虽然影响gp160的寡糖组成,但不会损害弗林蛋白酶或PACE4对gp160或gp120的加工。最后,[精氨酸355,精氨酸358] - α - 1抗胰蛋白酶波特兰变体的共表达被证明能有效抑制这些转化酶对gp160和gp120的加工。